Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of a Core Measurement Set for Research in Degenerative Cervical Myelopathy: A Study Protocol (Ao Spine Recode-Dcm Cms) Publisher Pubmed



Davies BM1 ; Yanez Touzet A2 ; Mowforth OD3 ; Lee KS4 ; Khan D5 ; Furlan JC6 ; Fehlings MG7 ; Harrop JS8 ; Zipser CM9 ; Rodriguespinto R10, 11 ; Milligan J12 ; Sarewitz E13 ; Curt A14 ; Rahimimovaghar V15 Show All Authors
Authors
  1. Davies BM1
  2. Yanez Touzet A2
  3. Mowforth OD3
  4. Lee KS4
  5. Khan D5
  6. Furlan JC6
  7. Fehlings MG7
  8. Harrop JS8
  9. Zipser CM9
  10. Rodriguespinto R10, 11
  11. Milligan J12
  12. Sarewitz E13
  13. Curt A14
  14. Rahimimovaghar V15
  15. Aarabi B16
  16. Boerger TF17
  17. Tetreault L18, 19
  18. Chen R20
  19. Guest JD21
  20. Kalsiryan S22
  21. Sadler I13
  22. Widdop S13
  23. Mcnair AGK23, 24
  24. Kwon BK25
  25. Kotter MRN26, 27
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
  2. 2. School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
  3. 3. Department of Academic Neurosurgery, University of Cambridge, Cambridge, United Kingdom
  4. 4. Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, United Kingdom
  5. 5. Academic Neurosurgery Unit, University College London, London, United Kingdom
  6. 6. Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Toronto, Toronto, ON, Canada
  7. 7. Division of Neurosurgery and Spinal Program, Toronto Western Hospital, Toronto, ON, Canada
  8. 8. Thomas Jefferson University, Jefferson Health System, St Louis, MO, United States
  9. 9. Neurology, University Hospital Balgrist, Zurich, Switzerland
  10. 10. Spinal Unit (UVM), Department of Orthopaedics, Centro Hospitalar Universitario Do Porto Epe, Porto, Portugal
  11. 11. Instituto de Ciencias Biomedicas Abel Salazar, Porto, Portugal
  12. 12. Family Medicine, McMaster University, Hamilton, ON, Canada
  13. 13. Myelopathy.org, Cambridge, United Kingdom
  14. 14. University Hospital Balgrist, Zurich, Switzerland
  15. 15. Academic Department of Neurological Surgery, Sina Trauma and Surgery Research Center, Tehran, Iran
  16. 16. Division of Neurosurgery, University of Maryland Baltimore, Baltimore, MD, United States
  17. 17. Neurosurgery, Medical College of Wisconsin, Wauwatosa, WI, United States
  18. 18. Department of Surgery, University of Toronto, Toronto, ON, Canada
  19. 19. Department of Medicine, University College Cork, Cork, Ireland
  20. 20. Neurology, Toronto Western Hospital, Toronto, ON, Canada
  21. 21. Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, United States
  22. 22. Toronto Rehabilitation Institute, Toronto, ON, Canada
  23. 23. Centre for Surgical Research, Bristol Medical School: Population Health Sciences, University of Bristol, Avon, Bristol, United Kingdom
  24. 24. Gi Surgery, North Bristol Nhs Trust, Bristol, United Kingdom
  25. 25. Department of Orthopaedics, University of British Columbia, Blusson Spinal Cord Center, Vancouver, BC, Canada
  26. 26. Department of Clinical Neurosurgery, University of Cambridge, Cambridge, United Kingdom
  27. 27. Department of Clinical Neurosciences, Ann McLaren Laboratory of Regenerative Medicine, Cambridge, United Kingdom

Source: BMJ Open Published:2022


Abstract

Introduction Progress in degenerative cervical myelopathy (DCM) is hindered by inconsistent measurement and reporting. This impedes data aggregation and outcome comparison across studies. This limitation can be reversed by developing a core measurement set (CMS) for DCM research. Previously, the AO Spine Research Objectives and Common Data Elements for DCM (AO Spine RECODE-DCM) defined € what' should be measured in DCM: the next step of this initiative is to determine € how' to measure these features. This protocol outlines the steps necessary for the development of a CMS for DCM research and audit. Methods and analysis The CMS will be developed in accordance with the guidance developed by the Core Outcome Measures in Effectiveness Trials and the Consensus-based Standards for the selection of health Measurement Instruments. The process involves five phases. In phase 1, the steering committee agreed on the constructs to be measured by sourcing consensus definitions from patients, professionals and the literature. In phases 2 and 3, systematic reviews were conducted to identify tools for each construct and aggregate their evidence. Constructs with and without tools were identified, and scoping reviews were conducted for constructs without tools. Evidence on measurement properties, as well as on timing of assessments, are currently being aggregated. These will be presented in phase 4: a consensus meeting where a multi-disciplinary panel of experts will select the instruments that will form the CMS. Following selection, guidance on the implementation of the CMS will be developed and disseminated (phase 5). A preliminary CMS review scheduled at 4 years from release. Ethics and dissemination Ethical approval was obtained from the University of Cambridge (HBREC2019.14). Dissemination strategies will include peer-reviewed scientific publications; conference presentations; podcasts; the identification of AO Spine RECODE-DCM ambassadors; and engagement with relevant journals, funders and the DCM community. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Experts (# of related papers)
Other Related Docs